Park H - Search Results

1

Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors among patients with heart failure with preserved ejection fraction.

Riaz M, Smith SM, Dietrich EA, Winchester DE, Guo J, Park H. Riaz M, et al. Among authors: park h. Pharmacotherapy. 2023 Oct;43(10):1024-1031. doi: 10.1002/phar.2853. Epub 2023 Jul 23. Pharmacotherapy. 2023. PMID: 37459069

2

Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis.

Park H, Park C, Kim Y, Rascati KL. Park H, et al. Among authors: park c. Ann Pharmacother. 2012 Nov;46(11):1453-69. doi: 10.1345/aph.1R041. Epub 2012 Nov 7. Ann Pharmacother. 2012. PMID: 23136353 Clinical Trial.

3

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.

Dawwas GK, Smith SM, Park H. Dawwas GK, et al. Among authors: park h. Cardiovasc Diabetol. 2018 Jul 17;17(1):102. doi: 10.1186/s12933-018-0746-4. Cardiovasc Diabetol. 2018. PMID: 30016946 Free PMC article.

4

Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes.

Dawwas GK, Smith SM, Park H. Dawwas GK, et al. Among authors: park h. Diabetes Obes Metab. 2019 Jan;21(1):28-36. doi: 10.1111/dom.13477. Epub 2018 Aug 16. Diabetes Obes Metab. 2019. PMID: 30039524

5

Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis.

Dawwas GK, Brown J, Dietrich E, Park H. Dawwas GK, et al. Among authors: park h. Lancet Haematol. 2019 Jan;6(1):e20-e28. doi: 10.1016/S2352-3026(18)30191-1. Epub 2018 Dec 14. Lancet Haematol. 2019. PMID: 30558988

6

Can apixaban prevent venous thromboembolism better than rivaroxaban? - Authors' reply.

Dawwas GK, Brown J, Dietrich E, Park H. Dawwas GK, et al. Among authors: park h. Lancet Haematol. 2019 Apr;6(4):e181-e182. doi: 10.1016/S2352-3026(19)30049-3. Lancet Haematol. 2019. PMID: 30926080 No abstract available.

7

Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis.

Dawwas GK, Dietrich E, Winchester DE, Winterstein AG, Segal R, Park H. Dawwas GK, et al. Among authors: park h. Pharmacotherapy. 2019 Sep;39(9):912-920. doi: 10.1002/phar.2311. Epub 2019 Aug 7. Pharmacotherapy. 2019. PMID: 31332815

8

Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace.

Dietrich E, Desai R, Garg M, Park H, Smith SM. Dietrich E, et al. Among authors: park h. J Clin Hypertens (Greenwich). 2020 Jan;22(1):6-15. doi: 10.1111/jch.13772. Epub 2019 Dec 24. J Clin Hypertens (Greenwich). 2020. PMID: 31873973 Free PMC article.

9

Twelve-year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States.

Dawwas GK, Leonard CE, Garg M, Vouri SM, Smith SM, Flory JH, Genuardi MV, Park H. Dawwas GK, et al. Among authors: park h. Diabetes Obes Metab. 2020 Apr;22(4):705-710. doi: 10.1111/dom.13949. Epub 2020 Jan 19. Diabetes Obes Metab. 2020. PMID: 31903713

10

Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism.

Dawwas GK, Smith SM, Dietrich E, Lo-Ciganic WH, Park H. Dawwas GK, et al. Among authors: park h. Am J Health Syst Pharm. 2020 Jan 24;77(3):188-195. doi: 10.1093/ajhp/zxz307. Am J Health Syst Pharm. 2020. PMID: 31974557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,501 results

Search Page

Filters